|
Report Date : |
02.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
SEI CHENG BIOTECHNOLOGY CO., LTD. |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
27.07.2009 |
|
|
|
|
Com. Reg. No.: |
24450223 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Trading of chemicals |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
--- |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
|
|
Supplied Address: |
|
|
Telephone Number: |
+886-4-8365121 |
|
Fax Number: |
Notes:
The exact subject’s name and address are as above mentioned.
|
Credit Opinion: |
|
Registered Name: |
Sei Cheng Biotechnology Co., Ltd. |
|
Registered Address: |
|
|
Date of Foundation: |
2009-7-27 |
|
Registration Number: |
24450223 |
|
Registry: |
Ministry of Economic Affairs Central Office |
|
Registered Capital: |
(As of 2012.04, 1 NTD = 0.033 USD) |
|
Paid-up Capital: |
NTD 30,000,000 (USD 990,000) |
|
Legal Representatives: |
Jinxiong Weng |
|
Legal Form: |
|
|
Principal Activities: |
|
|
Staff: |
|
|
Listed at Stock Exchange: |
|
|
Date of Last Annual Return: |
Subject declined to introduce its staff number.
Subject was incorporated on 2009-7-27 with registered
number 24450223 as Joint Stock Company in Taiwan.
Change of Name
|
Former Chinese Name |
协成生化科技股份有限公司 |
|
Current Chinese Name |
欣宏生化科技股份有限公司 |
|
Name |
Subscription Shares |
|
Jinxiong Weng |
100,000 |
|
Ruihong Weng |
|
|
300,000 |
|
|
Ruilong Weng |
300,000 |
|
Jinyuan Weng |
200,000 |
The information above is that of subject’s major shareholders.
Core
Management
|
1 |
|
|
Name |
Jinxiong Weng |
|
Position |
Chairman |
|
2 |
|
|
Name |
Ruihong Weng |
|
Position |
Director |
|
3 |
|
|
Name |
Ruilong Weng |
|
Position |
Director |
|
4 |
|
|
Name |
Jinyuan Weng |
|
Position |
Supervisor |
Offices
& Factories
|
|
Headquarters |
|
Add |
|
l
The registered activities of subject:
|
Business Code |
Details |
|
F102170 |
Wholesaling of food |
|
F107200 |
Wholesaling of chemical raw material |
|
F107990 |
Wholesaling of other chemicals |
|
F121010 |
Wholesaling of food additive |
|
F199990 |
Other wholesaling |
|
F203010 |
Retailing of food and beverage |
|
F207200 |
Retailing of chemical raw material |
|
F207990 |
Retailing of other chemicals |
|
F299990 |
Other retailing |
|
F401010 |
International trade |
|
ZZ99999 |
Besides licensed business, all other business
items those are not banned or restricted. |
l
The subject has a
proportion of 50% for Import.
l
The subject is mainly engaged in trading of various
chemicals.
l
Subject’s products include chemical raw material,
food additive, etc.
l
Subject has both domestic and foreign markets.
l
Subject exports according to orders.
l
The subject has a
proportion of 50% for export.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase
|
Payment Terms |
Proportion |
|
|
Chemicals |
COD, CBD, etc. |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Chemicals |
COD, CBD, etc. |
100% |
Sales
Domestic Markets
|
Sales Terms |
Proportion |
|
|
Chemicals |
COD, CBD, etc. |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Chemicals |
COD, CBD, etc. |
100% |
Subject has no obligations to disclose its financial statements to the
third party according to the relevant policy in Taiwan and the only source from
which we can obtain the information is the subject itself.
Subject’s relevant staff declined to disclose its financials citing the
grounds of company’s confidentiality; from other source we can not obtain the
relevant information, either.
Mortgage
No chattel
mortgage record of subject has been found within the recent 3 months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
Notes:
The woman who answered the telephone declined to introduce her name.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.68 |
|
UK Pound |
1 |
Rs.85.12 |
|
Euro |
1 |
Rs.69.38 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.